The global Rivaroxaban Market Growth Accelerated by Rising Adoption of Novel Anticoagulants

 


Rivaroxaban is an orally administered direct factor Xa inhibitor used as an alternative to warfarin for various indications such as treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Rivaroxaban offers advantages over traditional anticoagulants such as warfarin in terms of fixed dosing without need for routine coagulation monitoring.

The global Rivaroxaban Market is estimated to be valued at US$ 5,653 million in 2023 and is expected to exhibit a CAGR of 1.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growth of the global Rivaroxaban market is being accelerated by the rising adoption of novel oral anticoagulants (NOACs) over conventional vitamin K antagonists such as warfarin. Rivaroxaban has emerged as an effective alternative to warfarin due to its predictable pharmacokinetic and pharmacodynamic profile, lack of frequent coagulation monitoring, fewer drug-drug and drug-food interactions, and predictable anticoagulant response which translates to improved quality of life for patients. These advantages over warfarin have contributed significantly to the increased uptake of rivaroxaban, which is one of the key market trends driving the global Rivaroxaban market growth over the forecast period.

Segment Analysis
The global rivaroxaban market is dominated by the atrial fibrillation segment. Atrial fibrillation accounts for over 70% of the total market share as it is the most common cardiac arrhythmia encountered in clinical practice. Rivaroxaban has been proven effective for stroke prevention in patients with non-valvular atrial fibrillation and thus it has become the standard of care treatment in this patient segment.

Key Takeaways
The global rivaroxaban market is expected to witness high growth over the forecast period of 2023 to 2030. Favorable reimbursement policies and increasing prevalence of atrial fibrillation and venous thromboembolism are expected to drive the demand for rivaroxaban.

Regional analysis
North America dominates the global rivaroxaban market and is expected to continue its dominance in the coming years. This is attributed to the rising incidence of atrial fibrillation and deep vein thrombosis in the region. Asia Pacific is expected to witness the fastest growth over the forecast period owing to growing healthcare expenditures and increasing awareness regarding novel oral anticoagulants.

Key players
Key players operating in the rivaroxaban market are Janssen Pharmaceuticals Inc. and Bayer AG. Janssen Pharmaceuticals markets rivaroxaban under the brand name Xarelto. Bayer AG produces the active pharmaceutical ingredient for rivaroxaban and supplies it to marketing partner Janssen Pharmaceuticals.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more